Company Profiles

driven by the PitchBook Platform

Otic Pharma

Description

Developer of drugs for disorders of the ear, nose, and throat (ENT). The company provides products for the treatment of ENT disorders, based on FoamOtic, a proprietary foam-based drug delivery system providing sustained exposure of drugs. Its products includes a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD).

2008

Founded

PRIVATE

Status

1-10

Employees

Reverse Merger

Latest Deal Type

$4.3M

Total Amount Raised

6

Investors

Description

Developer of drugs for disorders of the ear, nose, and throat (ENT). The company provides products for the treatment of ENT disorders, based on FoamOtic, a proprietary foam-based drug delivery system providing sustained exposure of drugs. Its products includes a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD).

Website:

www.oticpharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

19900 MacArthur Boulevard Suite 550 Irvine, CA 92612United States +1 (949) 238-8090
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Otic Pharma's full profile, request a free trial.

    Otic Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Otic Pharma Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Incentive IncubatorAccelerator/Incubator000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    OrbiMedVenture CapitalMinority000 0000000 0000
    Peregrine VenturesVenture CapitalMinority000 0000000 0000
    Pontifax Venture CapitalVenture CapitalMinority000 0000000 0000
    Incentive Incubator Accelerator/Incubator
    Individual Investor Angel (individual)
    OrbiMed Venture Capital
    Peregrine Ventures Venture Capital
    Pontifax Venture Capital Venture Capital

    Otic Pharma Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Gregory FlesherChief Executive Officer, President & Board Member
    Christine OcampoChief Financial Officer & Senior Vice President
    Rodrigo Yelin Ph.DChief Operating Officer & Head, Research & Development
    Catherine Turkel Ph.DChief Development Officer
    Michael CruseVice President, Corporate Operations
    Gregory Flesher Chief Executive Officer, President & Board Member
    Christine Ocampo Chief Financial Officer & Senior Vice President
    Rodrigo Yelin Ph.D Chief Operating Officer & Head, Research & Development
    Catherine Turkel Ph.D Chief Development Officer
    Michael Cruse Vice President, Corporate Operations

    Otic Pharma Board Members (8)

    NameRepresentingRoleSinceContact
    Info
    Chen SchorSelfBoard Member000 0000
    Eran Eilat MDSelfBoard Member000 0000
    Erez ChimovitsOrbiMedSenior Managing Director000 0000
    Eyal LifschitzPeregrine VenturesCo-Founder, Chief Executive Officer & General Partner000 0000
    Gregory FlesherOtic PharmaChief Executive Officer, President & Board Member000 0000
    Chen Schor Board Member Self
    Eran Eilat MD Board Member Self
    Erez Chimovits Senior Managing Director OrbiMed
    Eyal Lifschitz Co-Founder, Chief Executive Officer & General Partner Peregrine Ventures
    Gregory Flesher Chief Executive Officer, President & Board Member Otic Pharma
    Request full access to PitchBook